Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Helle Keinicke"'
Autor:
Helle Keinicke, Gao Sun, Caroline M Junker Mentzel, Merete Fredholm, Linu Mary John, Birgitte Andersen, Kirsten Raun, Marina Kjaergaard
Publikováno v:
Endocrine Connections, Vol 9, Iss 8, Pp 755-768 (2020)
The prevalence of non-alcoholic fatty liver disease (NAFLD) has increased dramatically worldwide and, subsequently, also the risk of developing non-alcoholic steatohepatitis (NASH), hepatic fibrosis, cirrhosis and cancer. Today, weight lo ss is the o
Externí odkaz:
https://doaj.org/article/e68e13f481f74afe897403913b097076
Autor:
Caroline M Junker Mentzel, Ferhat Alkan, Helle Keinicke, Mette J Jacobsen, Jan Gorodkin, Merete Fredholm, Susanna Cirera
Publikováno v:
PLoS ONE, Vol 11, Iss 11, p e0167285 (2016)
Obesity and its comorbidities are an increasing challenge for both affected individuals and health care systems, worldwide. In obese individuals, perturbation of expression of both protein-coding genes and microRNAs (miRNA) are seen in obesity-releva
Externí odkaz:
https://doaj.org/article/28b2ef31f04a4270b3a85ea2033c7c65
Autor:
Kirsten Raun, Helle Keinicke, Gao Sun, Birgitte Andersen, Merete Fredholm, Linu M. John, Marina Kjaergaard, Caroline M. Junker Mentzel
Publikováno v:
Endocrine Connections, Vol 9, Iss 8, Pp 755-768 (2020)
Endocrine Connections
Keinicke, H, Sun, G, Mentzel, C M J, Fredholm, M, John, L M, Andersen, B, Raun, K & Kjaergaard, M 2020, ' Fgf21 regulates hepatic metabolic pathways to improve steatosis and inflammation ', Endocrine Connections, vol. 9, no. 8, pp. 755-768 . https://doi.org/10.1530/EC-20-0152
Endocrine Connections
Keinicke, H, Sun, G, Mentzel, C M J, Fredholm, M, John, L M, Andersen, B, Raun, K & Kjaergaard, M 2020, ' Fgf21 regulates hepatic metabolic pathways to improve steatosis and inflammation ', Endocrine Connections, vol. 9, no. 8, pp. 755-768 . https://doi.org/10.1530/EC-20-0152
The prevalence of non-alcoholic fatty liver disease (NAFLD) has increased dramatically worldwide and, subsequently, also the risk of developing non-alcoholic steatohepatitis (NASH), hepatic fibrosis, cirrhosis and cancer. Today, weight loss is the on
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5b1b8aa4c65fcc8781460b252b5636c7
https://ec.bioscientifica.com/view/journals/ec/9/8/EC-20-0152.xml
https://ec.bioscientifica.com/view/journals/ec/9/8/EC-20-0152.xml
Publikováno v:
Molecular Cancer Therapeutics. 17:A143-A143
Introduction: Drug repurposing has emerged as an attractive alternative to the classical pipeline of drug development for novel anticancer drugs. We have selected disulfiram, which was FDA approved for treatment of alcoholism already in 1951. Disulfi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f1f4c05ad2b700ed8200931b227f22bd
https://doi.org/10.1158/1535-7163.targ-17-a143
https://doi.org/10.1158/1535-7163.targ-17-a143